Fact Sheet | Bundled Payment

CMMI End-Stage Renal Disease Treatment Choices Model: HFMA Overview

Fact Sheet | Bundled Payment

CMMI End-Stage Renal Disease Treatment Choices Model: HFMA Overview

On July 10, 2019, the Center for Medicare & Medicaid Innovation (CMMI) proposed the End-Stage Renal Disease (ERSD) Treatment Choices (ETC) Model, a six-and-a-half-year mandatory payment model focused on beneficiaries with ESRD. The model is designed to increase the use of in-home dialysis (as opposed to in-facility, which is the predominant model) and kidney transplantation rates by adjusting payments to clinicians and ESRD facilities based on their patients’ rates of home dialysis and transplantation. The model will run from January 1, 2020 through June 30, 2026.

Download the overview

Advertisements

Related Articles | Bundled Payment

News | Bundled Payment

After big payouts, Medicare may throttle back bundled payment program

Most BPCI-A participants could see bonuses dry up if proposed changes in the program are implemented.

News | Coronavirus

Bundled payment participants face choices on 2020 performance measurement, continued participation

CMS further detailed how hospitals should evaluate their 2020 options and whether to continue in the BPCI-A model.

News | Coronavirus

Where are Medicare value-based payment models headed after COVID-19?

The pandemic-driven changes in policies, payment and patient attitudes could change participation in and provider approaches to value-based payment models, say advisers.

News | Bundled Payment

Mandatory bundled payment program for joint replacement makes changes to accommodate hospitals during COVID-19

Medicare’s largest mandatory bundled payment program is striving to adapt to the unique challenges the coronavirus has created for its hospital participants.